Scaffold Technology - Global Market Trajectory & Analytics

Global Scaffold Technology Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Scaffold Technology estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027. Hydrogels, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$772.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymeric Scaffolds segment is readjusted to a revised 6.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $303.4 Million, While China is Forecast to Grow at 7.2% CAGR

The Scaffold Technology market in the U.S. is estimated at US$303.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$300.6 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Micropatterned Surface Microplates Segment to Record 7.3% CAGR

In the global Micropatterned Surface Microplates segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$117.3 Million in the year 2020 will reach a projected size of US$192.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$198.9 Million by the year 2027.

Select Competitors (Total 34 Featured):

3D Biotek LLC
Avacta Life Sciences Limited
Becton
Corning Inc.
Dickinson and Company
Marticel GmbH
Merck and Company
Molecular Matrix Inc.
Nanofiber Solutions
NuVasive, Inc.
Pelo Biotech GmbH
ReproCELL Europe Ltd.
Tecan Trading AG
Thermo Fisher Scientific Inc.

Frequently Asked Questions about the Global Market for Scaffold Technology

What is the estimated value of the Global Market for Scaffold Technology?

The Global Market for Scaffold Technology was estimated to be valued at $1.0 Billion in 2020.

What is the growth rate of the Global Market for Scaffold Technology?

The growth rate of the Global Market for Scaffold Technology is 7.9%, with an estimated value of $1.7 Billion by 2027.

What is the forecasted size of the Global Market for Scaffold Technology?

The Global Market for Scaffold Technology is estimated to be worth $1.7 Billion by 2027.

Who are the key companies in the Global Market for Scaffold Technology?

Key companies in the Global Market for Scaffold Technology include 3D Biotek LLC, Avacta Life Sciences Limited, Becton, Corning Inc., Dickinson and Company, Marticel GmbH, Merck and Company, Molecular Matrix Inc. and NuVasive, Inc..

Report Attribute	Details
Published	April 2021
Forecast Period	2020 - 2027
Estimated Market Value ( USD ) in 2020	$ 1 Billion
Forecasted Market Value ( USD ) by 2027	$ 1.7 Billion
Compound Annual Growth Rate	7.9%

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for Scaffold Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
Table 3: World Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 4: World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 5: World Current & Future Analysis for Polymeric Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 6: World 7-Year Perspective for Polymeric Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 7: World Current & Future Analysis for Micropatterned Surface Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World 7-Year Perspective for Micropatterned Surface Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 9: World Current & Future Analysis for Nanofiber Based Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 10: World 7-Year Perspective for Nanofiber Based Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 11: World Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 12: World 7-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 13: World Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World 7-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 15: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 16: World 7-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 17: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 18: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 20: USA 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 21: USA Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 22: USA 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
CANADA
Table 23: Canada Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 24: Canada 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 25: Canada Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 26: Canada 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
JAPAN
Table 27: Japan Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 28: Japan 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 29: Japan Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 30: Japan 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
CHINA
Table 31: China Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 32: China 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 33: China Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 34: China 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
EUROPE
Table 35: Europe Current & Future Analysis for Scaffold Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 36: Europe 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Table 37: Europe Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 39: Europe Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 40: Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
FRANCE
Table 41: France Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 42: France 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 43: France Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: France 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
GERMANY
Table 45: Germany Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 46: Germany 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 47: Germany Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 48: Germany 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
ITALY
Table 49: Italy Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Italy 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 51: Italy Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 52: Italy 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
UNITED KINGDOM
Table 53: UK Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 54: UK 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 55: UK Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: UK 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
REST OF EUROPE
Table 57: Rest of Europe Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 58: Rest of Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 59: Rest of Europe Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 60: Rest of Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
ASIA-PACIFIC
Table 61: Asia-Pacific Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Asia-Pacific 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 63: Asia-Pacific Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 64: Asia-Pacific 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
REST OF WORLD
Table 65: Rest of World Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 66: Rest of World 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
Table 67: Rest of World Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 68: Rest of World 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 34

Companies Mentioned

A selection of companies mentioned in this report includes:

3D Biotek LLC
Avacta Life Sciences Limited
Becton
Corning Inc.
Dickinson and Company
Marticel GmbH
Merck and Company
Molecular Matrix Inc.
Nanofiber Solutions
NuVasive, Inc.
Pelo Biotech GmbH
ReproCELL Europe Ltd.
Tecan Trading AG
Thermo Fisher Scientific Inc.

What is the estimated value of the Global Market for Scaffold Technology?

What is the growth rate of the Global Market for Scaffold Technology?

What is the forecasted size of the Global Market for Scaffold Technology?

Who are the key companies in the Global Market for Scaffold Technology?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Scaffold Technology Market Research Report by Product (Freeze Embryo Testing, Hydrogels, and Micropatterned Surface Microplates), End-User, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Scaffold Technology Market Research Report by Product (Freeze Embryo Testing, Hydrogels, and Micropatterned Surface Microplates), End-User, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Surgical Scaffolds Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

Hernia Repair Devices (General Surgery) - Medical Devices Pipeline Product Landscape, 2021

Global Spinal Fusion Devices Market Size, Share & Industry Trends Analysis Report By Surgery, By Type, By End User (Hospitals, Specialty Clinics, and Others), By Regional Outlook and Forecast, 2022 - 2028